Archit Organosys Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Kandarp Amin

Chief executive officer

₹8.4m

Total compensation

CEO salary percentage	100.0%
CEO tenure	24.8yrs
CEO ownership	34.1%
Management average tenure	no data
Board average tenure	4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Kandarp Amin's remuneration changed compared to Archit Organosys's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	₹33m
Jun 30 2024	n/a	n/a	₹26m
Mar 31 2024	₹8m	₹8m	₹33m
Dec 31 2023	n/a	n/a	₹34m
Sep 30 2023	n/a	n/a	₹61m
Jun 30 2023	n/a	n/a	₹88m
Mar 31 2023	₹8m	₹8m	₹113m
Dec 31 2022	n/a	n/a	₹113m
Sep 30 2022	n/a	n/a	₹111m
Jun 30 2022	n/a	n/a	₹94m
Mar 31 2022	₹8m	₹8m	₹82m
Dec 31 2021	n/a	n/a	₹79m
Sep 30 2021	n/a	n/a	₹74m
Jun 30 2021	n/a	n/a	₹71m
Mar 31 2021	₹8m	₹8m	₹50m
Dec 31 2020	n/a	n/a	₹29m
Sep 30 2020	n/a	n/a	₹8m
Jun 30 2020	n/a	n/a	-₹8m
Mar 31 2020	₹8m	₹8m	-₹8m
Dec 31 2019	n/a	n/a	₹497k
Sep 30 2019	n/a	n/a	-₹19m
Jun 30 2019	n/a	n/a	-₹25m
Mar 31 2019	₹6m	₹6m	-₹47m
Dec 31 2018	n/a	n/a	-₹41m
Sep 30 2018	n/a	n/a	-₹10m
Jun 30 2018	n/a	n/a	₹11m
Mar 31 2018	₹5m	₹5m	₹5m

Compensation vs Market: Kandarp's total compensation ($USD99.45K) is above average for companies of similar size in the Indian market ($USD42.70K).

Compensation vs Earnings: Kandarp's compensation has been consistent with company performance over the past year.

CEO

Kandarp Amin (67 yo)

24.8yrs

Tenure

₹8,400,000

Compensation

Mr. Kandarp Krishnakant Amin serves as Chairman of Archit Organosys Limited and has been its Whole-Time Director since January 22, 2000. He joined Archit Organosys Limited since January 22, 2000. He has ex...

Board Members

Name	Position	Tenure	Compensation	Ownership
Kandarp Amin	Chairman	24.8yrs	₹8.40m	34.15% ₹ 302.3m
Archana Amin	Whole-Time Director	25.2yrs	₹7.80m	22.19% ₹ 196.5m
Archit Amin	Whole Time Director	7.5yrs	₹6.60m	8.3% ₹ 73.5m
Nikul Patel	Independent Non-Executive Director	3.3yrs	₹20.00k	0.000010% ₹ 88.5
Shreeraj Desai	Independent Non-Executive Director	4.8yrs	₹15.00k	no data
Vatsal Vora	Additional Independent Director	1.4yrs	₹5.00k	no data
Bhavin Shah	Additional Independent Director	1.4yrs	₹5.00k	0.074% ₹ 653.6k

4.8yrs

Average Tenure

41yo

Average Age

Experienced Board: 524640's board of directors are considered experienced (4.8 years average tenure).

Archit Organosys Management

Management criteria checks 2/4

Key information

Recent management updates

Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer

Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Recent updates

New major risk - Financial position

Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer

Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.77 in 1Q 2024)

Archit Organosys Limited to Report Q1, 2025 Results on Aug 08, 2024

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Investor sentiment improves as stock rises 25%

Full year 2024 earnings released: EPS: ₹1.60 (vs ₹5.53 in FY 2023)

New major risk - Market cap size

Archit Organosys Limited to Report Q4, 2024 Results on May 30, 2024

Investor sentiment improves as stock rises 18%

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Now 20% undervalued after recent price drop

New major risk - Market cap size

Third quarter 2024 earnings released: ₹0.22 loss per share (vs ₹1.09 profit in 3Q 2023)

New minor risk - Profit margin trend

Archit Organosys Limited Declares Dividend

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited to Report Q3, 2024 Results on Feb 14, 2024

Upcoming dividend of ₹0.50 per share at 1.0% yield

Archit Organosys Limited Proposes Declare

Archit Organosys Limited to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₹0.50 per share at 0.9% yield

Archit Organosys Limited, Annual General Meeting, Aug 22, 2023

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited Recommends a Final Dividend for the Financial Year Ended March 31, 2023

Chairman & Whole Time Director recently bought ₹507k worth of stock

Chairman & Whole Time Director recently bought ₹1.3m worth of stock

Investor sentiment deteriorated over the past week

Third quarter 2023 earnings released: EPS: ₹1.09 (vs ₹0.99 in 3Q 2022)

Archit Organosys Limited to Report Q3, 2023 Results on Jan 13, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Archit Organosys Limited to Report Q2, 2023 Results on Nov 11, 2022

Archit Organosys Limited Announces Chief Financial Officer Changes

Investor sentiment improved over the past week

Archit Organosys Limited Approves Dividend

Investor sentiment improved over the past week

Archit Organosys Limited, Annual General Meeting, Sep 08, 2022

First quarter 2023 earnings released: EPS: ₹2.01 (vs ₹1.42 in 1Q 2022)

Archit Organosys Limited to Report Q1, 2023 Results on Jul 25, 2022

Archit Organosys Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Archit Organosys Limited Announces Appointment of Vijay A. Boliya as Company Secretary and Compliance Officer, Effective March 1, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Archit Organosys Limited Announces Resignation of Anchal Bansal as Company Secretary and Compliance Officer

Second quarter 2022 earnings released: EPS ₹0.68 (vs ₹0.70 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹1.42 (vs ₹0.55 in 1Q 2021)

Independent Director Rajendraprasad Shah has left the company

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹3.33 (vs ₹0.53 loss in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹1.02 (vs ₹0.37 loss in 3Q 2020)

Archit Organosys Limited to Report Q3, 2021 Results on Feb 13, 2021

Investor sentiment improved over the past week

New 90-day high: ₹25.00

New 90-day high: ₹24.55

Investor sentiment deteriorated over the past week

New 90-day high: ₹23.80